Tag: Indian Pharma

spot_imgspot_img

Pradhan Mantri Bhartiya Janaushadhi Pariyojana Records ₹2,252.19 Crore in Sales for FY 2025–26, Saving Citizens ₹9,000 Crore

The Department of Pharmaceuticals announced that the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) achieved total sales of ₹2,252.19 crore in the financial year 2025–26. The widespread availability of quality...

Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️

Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of Phase II Proof-of-Concept trials and approval...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical System, the company announced July 23...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...

FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.

 A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...